772
AIM: Report of a case of a woman patient who developed celiac disease after pegylated interferon alpha-2a and ribavirin use for chronic hepatitis C.
 a woman patient: Subject; woman: Subject.Gender; celiac disease: Effect; pegylated interferon alpha-2a and ribavirin use for chronic hepatitis C.: Treatment; pegylated interferon alpha-2a: Treatment.Drug; ribavirin: Treatment.Drug; chronic hepatitis C.: Treatment.Disorder; ribavirin: Combination.Drug; pegylated interferon alpha-2a: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a woman patient: Subject; woman: Subject.Gender; celiac disease: Effect; pegylated interferon alpha-2a and ribavirin use for chronic hepatitis C.: Treatment; pegylated interferon alpha-2a: Treatment.Drug; ribavirin: Treatment.Drug; chronic hepatitis C.: Treatment.Disorder; ribavirin: Combination.Drug; pegylated interferon alpha-2a: Combination.Drug